Senators want probe of biologic companies’ practices
Senate Judiciary Committee Chairman Charles Grassley and Senator Amy Klobuchar have asked the Federal Trade Commission to investigate whether makers of biologic medicines are using practices that hinder or delay biosimilars...To view the full article, register now.
Already a subscriber? Click here to view full article